GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Fushilai Pharmaceutical Co Ltd (SZSE:301258) » Definitions » Days Sales Outstanding

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Days Sales Outstanding : 58.28 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Fushilai Pharmaceutical Co Days Sales Outstanding?

Suzhou Fushilai Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥61.5 Mil. Suzhou Fushilai Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥96.3 Mil. Hence, Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 58.28.

The historical rank and industry rank for Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SZSE:301258' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.78   Med: 64.5   Max: 88.85
Current: 59.29

During the past 11 years, Suzhou Fushilai Pharmaceutical Co's highest Days Sales Outstanding was 88.85. The lowest was 56.78. And the median was 64.50.

SZSE:301258's Days Sales Outstanding is ranked better than
61.04% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs SZSE:301258: 59.29

Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2023 (49.41) to Mar. 2024 (58.28).


Suzhou Fushilai Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Fushilai Pharmaceutical Co Days Sales Outstanding Chart

Suzhou Fushilai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.48 64.73 57.79 57.04 56.78

Suzhou Fushilai Pharmaceutical Co Quarterly Data
Jun18 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.41 51.14 74.07 57.89 58.28

Competitive Comparison of Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding

For the Biotechnology subindustry, Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding falls into.



Suzhou Fushilai Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (92.143 + 60.086) / 2 ) / 489.293*365
=76.1145 / 489.293*365
=56.78

Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (60.086 + 62.907) / 2 ) / 96.291*365 / 4
=61.4965 / 96.291*365 / 4
=58.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Fushilai Pharmaceutical Co  (SZSE:301258) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Suzhou Fushilai Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Suzhou Fushilai Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Business Description

Traded in Other Exchanges
N/A
Address
No. 16, Haiwang Road, New Material Industrial Park, Jiangsu Province, Changshu, CHN, 215500
Suzhou Fushilai Pharmaceutical Co Ltd is engaged in the Research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have significant effects in anti-oxidation, anti-aging, and blood sugar improvement.
Executives
Qian Yi Supervisors

Suzhou Fushilai Pharmaceutical Co (SZSE:301258) Headlines

No Headlines